MDMG provides corporate update at DB CEEMEA Conf.

MD Medical Group to attend and provide update at the 2nd Annual Deutsche Bank dbAccess CEEMEA Conference in London

23 January, 2014 - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), Russia's leading provider of private women's and children's healthcare, announces today that Elena Mladova, Chief Executive Officer, and Vitaly Ustimenko, Chief Financial Officer, will attend the Deutsche Bank dbAccess CEEMEA Conference at the Andaz Hotel, London on 23-24 January 2014.

During the meetings with investors, MDMG will provide a corporate and operational update and, when commenting on the outlook for 2014, management will say:

"We will continue our expansion in line with our mid-term strategy to construct our own hospitals in Russia's largest regions, to open and to acquire successful outpatient medical centres, in order to retain our focus on core business areas whilst moving in to new diagnostic areas. At the same time we will maintain our high quality of services and patient care.

"We expect to benefit further from the continued successful ramp up of Lapino, the consolidation of Samara and Irkutsk clinics, the opening of new outpatient clinics and our overall budget discipline and cost control.

"With our solid CapEx position we are well placed to grow and deliver on our promises including the opening of Ufa hospital by early 2015, the start of construction in Yekaterinburg in 2014 and Nizhniy Novgorod in 2015. We are also considering a number of smaller scale regional expansion projects in Russia in 2014."

For more information about MD Medical Group, please visit the Company's web site at www.mcclinics.com, or contact:

EM - Moscow

Tom Blackwell / Sergii Pershyn

Tel: +7 495 363 2842

MDMG@em-comms.com

Consilium Strategic Communications - London

Emma Thompson / Matthew Neal

Tel: +44 20 7920 2354

MDMG@em-comms.com

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 17 modern healthcare facilities, including 2 hospitals and 15 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk and Yaroslavl. In addition, 3 franchised outpatient clinics operate in Kyiv, Ukraine.

The Company's main medical facilities are the Perinatal Medical Center (PMC), a 250-bed medical centre, which opened its doors in 2006, and Lapino hospital, a 182-bed medical centre, which opened at the end of 2012. In 2013, there were 3,816 deliveries in PMC and Lapino. The number of outpatient treatments for 2013 in PMC and the Company's outpatient clinics totalled 627,247. In March 2013, the Company began construction of its third hospital in Ufa. In April 2013 MD Medical Group completed the acquisition of the IDK Medical Company, a network of women's and children's health clinics located in the Russian region of Samara ("IDK") and acquired Mother&Child clinic in Irkutsk in May 2013, which had previously operated through a franchise agreement with MD Medical Group. The same month the Company completed a large-scale modernisation project of its Mother & Child Health Clinic in Moscow. In December 2013, a new outpatient clinic was opened in Yaroslavl which became the first healthcare facility in the region to provide IVF services.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.